SEC Obtains Final Judgments in CanaFarma Hemp Fraud Case

The owners misrepresented their company as a fully integrated hemp farm and processor.

I Stock 825329888
iStock/nevodka

On April 10, 2025, the U.S. District Court for the Southern District of New York entered final judgments against Frank Barone and Kirill Chumenko, both former Senior Vice Presidents of Sales & Marketing at CanaFarma Hemp Products Corp., enjoining them from violating certain provisions of the federal securities laws and imposing five-year officer-and-director and penny stock bars.

The SEC's amended complaint, filed on November 28, 2023, alleged that, in 2019 and 2020, Barone and Chumenko, along with CanaFarma and its two co-founders, Vitaly Fargesen and Igor Palatnik, raised millions of dollars from investors. While raising these funds purportedly to operate CanaFarma, Fargesen and Palatnik allegedly made misrepresentations to investors, including claims that CanaFarma was a fully integrated company that was processing hemp from its own farm, when in fact it had not processed any hemp and its products used hemp oil supplied by third parties. The amended complaint alleged that Barone and Chumenko, at the direction of Fargesen, made unsupported changes to CanaFarma's financial model in order to disguise an expected series of payments to Fargesen and Palatnik. Additionally, the amended complaint alleged that Fargesen and Palatnik - in some instances with the assistance of Barone and Chumenko - misappropriated at least $4 million of investor funds.

Previously, on December 1, 2023, the Court entered consent judgments against Barone and Chumenko in which they agreed to be permanently enjoined from violations of these charged provisions and agreed to officer-and-director and penny stock bars, the length of which were to be determined at a later date. The final consent judgments against Barone and Chumenko, entered by the Court on April 10, 2025, reimposed that permanent injunctive relief for violations of the charged provisions and imposed five-year officer and director and penny stock bars.

On November 14, 2024, the SEC voluntarily dismissed its complaint against CanaFarma. The entry of the final judgments as to Barone and Chumenko conclude the SEC's litigation in this matter.

More in News